PubMed

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.

Silverberg MJ, Leyden W, Hurley L, Go AS, Quesenberry CP Jr, Klein D, Horberg MA.

Ann Intern Med. 2009 Mar 3;150(5):301-13.PMID: 19258558 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection.

[No authors listed]

Ann Intern Med. 2009 Mar 3;150(5):I38. No abstract available. PMID: 19258553 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.

Rimland D, Guest JL, Hernández I, Del Rio C, Le NA, Brown WV.

HIV Med. 2005 Sep;6(5):326-33.PMID: 16156880 [PubMed - indexed for MEDLINE]Related articles

Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.

Nguyen ST, Eaton SA, Bain AM, Rahman AP, Payne KD, Bedimo R, Herrington JD, Maclayton DO, Rodriguez-Barradas MC, Busti AJ.

Pharmacotherapy. 2008 Mar;28(3):323-30.PMID: 18294112 [PubMed - indexed for MEDLINE]Related articles

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.

McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A; First Pediatric Switch Study.

Pediatrics. 2003 Mar;111(3):e275-81.PMID: 12612284 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.

Rahman AP, Eaton SA, Nguyen ST, Bain AM, Payne KD, Bedimo R, Busti AJ.

Pharmacotherapy. 2008 Jul;28(7):913-9.PMID: 18576906 [PubMed - indexed for MEDLINE]Related articles

Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.

Clin Ther. 2007 Jul;29(7):1448-55.PMID: 17825696 [PubMed - indexed for MEDLINE]Related articles

Evaluation and management of dyslipidemia in patients with HIV infection.

Green ML.

J Gen Intern Med. 2002 Oct;17(10):797-810. Review.PMID: 12390557 [PubMed - indexed for MEDLINE]Related articlesFree article

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.PMID: 17919548 [PubMed - indexed for MEDLINE]Related articles

Lipid management in patients who have HIV and are receiving HIV therapy.

Aberg JA.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):207-22. Review.PMID: 19217520 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.

Young J, Weber R, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.

Antivir Ther. 2005;10(5):585-91.PMID: 16152752 [PubMed - indexed for MEDLINE]Related articles

Comparison between duration dependent effects of Simvastatin and Gemfibrozil on dyslipidemia in patients with type 2 diabetes.

Ashraf R, Amir K, Shaikh AR.

J Pak Med Assoc. 2005 Aug;55(8):324-7.PMID: 16164158 [PubMed - indexed for MEDLINE]Related articles

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.

Cooke CE, Hammerash WJ Jr.

Clin Ther. 2006 Apr;28(4):591-9.PMID: 16750470 [PubMed - indexed for MEDLINE]Related articles

[Rosuvastatin for the treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy. Preliminary experience]

Bottaro EG, Caravello O, Scapellato PG, Stambulian M, Vidal GI, Loggia V, Scapellato JL, Thompson F, Cassetti I.

Enferm Infecc Microbiol Clin. 2008 Jun-Jul;26(6):325-9. Spanish. PMID: 18588813 [PubMed - indexed for MEDLINE]Related articlesFree article

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.

Visnegarwala F, Maldonado M, Sajja P, Minihan JL, Rodriguez-Barradas MC, Ong O, Lahart CJ, Hasan MQ, Balasubramanyam A, White AC Jr.

J Infect. 2004 Nov;49(4):283-90.PMID: 15474625 [PubMed - indexed for MEDLINE]Related articles

Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.

Martínez E, Tuset M, Milinkovic A, Miró JM, Gatell JM.

Antivir Ther. 2004 Oct;9(5):649-63. Review.PMID: 15535403 [PubMed - indexed for MEDLINE]Related articles

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.

Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM.

Ann Intern Med. 1996 Oct 1;125(7):529-40.PMID: 8815751 [PubMed - indexed for MEDLINE]Related articlesFree article

[Lipid disorders in patients with HIV-induced diseases]

Chanu B, Valensi P.

Presse Med. 2005 Sep 10;34(15):1087-94. Review. French. PMID: 16334888 [PubMed - indexed for MEDLINE]Related articles